CureVac
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CureVac and other ETFs, options, and stocks.About CVAC
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy.
CEOAlexander Zehnder
CEOAlexander Zehnder
Employees983
Employees983
HeadquartersTübingen, Baden Wuerttemberg
HeadquartersTübingen, Baden Wuerttemberg
Founded2020
Founded2020
Employees983
Employees983
CVAC Key Statistics
Market cap1.16B
Market cap1.16B
Price-Earnings ratio7.12
Price-Earnings ratio7.12
Dividend yield—
Dividend yield—
Average volume2.57M
Average volume2.57M
High today$5.16
High today$5.16
Low today$5.10
Low today$5.10
Open price$5.12
Open price$5.12
Volume400.44K
Volume400.44K
52 Week high$5.72
52 Week high$5.72
52 Week low$2.48
52 Week low$2.48
Stock Snapshot
With a market cap of 1.16B, CureVac(CVAC) trades at $5.12. The stock has a price-to-earnings ratio of 7.12.
During the trading session on 2025-12-07, CureVac(CVAC) shares reached a daily high of $5.16 and a low of $5.10. At a current price of $5.12, the stock is +0.4% higher than the low and still -0.8% under the high.
Trading activity shows a volume of 400.44K, compared to an average daily volume of 2.57M.
The stock's 52-week range extends from a low of $2.48 to a high of $5.72.
The stock's 52-week range extends from a low of $2.48 to a high of $5.72.
People also own
Based on the portfolios of people who own CVAC. This list is generated using Robinhood data, and it’s not a recommendation.